Back

Low-dose interleukin-2 for the reduction of vascular inflammation in acute coronary syndromes (IVORY) / IVORY - Clinical Outcomes And Follow-up (IVORY FINALE) Study

30 August 2024 (08:00 - 17:30)
Organised by: Logo
Congress Presentation Part of: Smaller trials, trial updates, and other studies on inflammation and immunity in cardiovascular disease Pharmacotherapy ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Doctor Rouchelle Sriranjan

Royal Papworth Hospital, Cambridge (United Kingdom of Great Britain & Northern Ireland)

7 More presentations in this session

Presentation thumbnail
Anakinra versus placebo double blind Randomized controlled trial for the treatment of Acute MyocarditIS
Professor M. Kerneis (Paris, FR)
Slides Video
Presentation thumbnail
Colchicine for secondary prevention of stroke and other cardiovascular events: a meta-analysis of randomised trials
Doctor A. Fiolet (Utrecht, NL)
Slides Video
Presentation thumbnail
Cardiovascular benefit of colchicine in relation to baseline risk
Mr N. Mohammadnia (Nijmegen, NL)
Slides Video
Presentation thumbnail
Effect of pre-hospital pulse-dose glucocorticoid on infarct size in st-segment elevation myocardial infarction: a randomized, blinded, placebo-controlled clinical trial
Doctor J. Marquard (Copenhagen, DK)
Slides Video
Presentation thumbnail
Randomized double-blind trial to study the benefit of Colchicine in Patients with Acutely Decompensated Heart Failure
Professor D. Pascual Figal (Murcia, ES)
Slides Video

Access the full session

Session thumbnail
Smaller trials, trial updates, and other studies on inflammation and immunity in cardiovascular disease
Video

The Event

Event poster

ESC Congress 2024

30 August - 2 September 2024

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources